nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0707	0.28	CbGbCtD
Donepezil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0442	0.175	CbGbCtD
Donepezil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0411	0.163	CbGbCtD
Donepezil—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0303	0.12	CbGbCtD
Donepezil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0189	0.0747	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0186	0.0734	CbGbCtD
Donepezil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0173	0.0684	CbGbCtD
Donepezil—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0165	0.274	CbGeAlD
Donepezil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0118	0.0467	CbGbCtD
Donepezil—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00604	0.1	CbGeAlD
Donepezil—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00565	0.0938	CbGeAlD
Donepezil—HRH3—brainstem—peripheral nervous system neoplasm	0.0049	0.0813	CbGeAlD
Donepezil—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00431	0.0714	CbGeAlD
Donepezil—HTR2A—pons—peripheral nervous system neoplasm	0.00426	0.0706	CbGeAlD
Donepezil—ACHE—trigeminal ganglion—peripheral nervous system neoplasm	0.003	0.0497	CbGeAlD
Donepezil—HRH3—cerebellum—peripheral nervous system neoplasm	0.00242	0.0401	CbGeAlD
Donepezil—HTR2A—nerve—peripheral nervous system neoplasm	0.00221	0.0366	CbGeAlD
Donepezil—HTR2A—ganglion—peripheral nervous system neoplasm	0.00218	0.0362	CbGeAlD
Donepezil—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.00201	0.0333	CbGeAlD
Donepezil—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.0019	0.0314	CbGeAlD
Donepezil—ACHE—cerebellum—peripheral nervous system neoplasm	0.00131	0.0217	CbGeAlD
Donepezil—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00117	0.0893	CbGpPWpGaD
Donepezil—HTR2A—brainstem—peripheral nervous system neoplasm	0.000947	0.0157	CbGeAlD
Donepezil—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.000877	0.0145	CbGeAlD
Donepezil—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000863	0.0143	CbGeAlD
Donepezil—HRH3—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000758	0.0579	CbGpPWpGaD
Donepezil—HTR2A—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000718	0.0548	CbGpPWpGaD
Donepezil—ACHE—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.000665	0.0508	CbGpPWpGaD
Donepezil—ACHE—Synthesis, secretion, and deacylation of Ghrelin—BCHE—peripheral nervous system neoplasm	0.00064	0.0488	CbGpPWpGaD
Donepezil—Doxazosin—ABCB1—peripheral nervous system neoplasm	0.000636	1	CrCbGaD
Donepezil—ACHE—Synthesis of PC—BCHE—peripheral nervous system neoplasm	0.000586	0.0447	CbGpPWpGaD
Donepezil—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000467	0.00775	CbGeAlD
Donepezil—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000426	0.00706	CbGeAlD
Donepezil—ACHE—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000363	0.0277	CbGpPWpGaD
Donepezil—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000361	0.0276	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000336	0.0256	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000268	0.0205	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000254	0.0194	CbGpPWpGaD
Donepezil—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000236	0.018	CbGpPWpGaD
Donepezil—ACHE—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000222	0.017	CbGpPWpGaD
Donepezil—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000321	CcSEcCtD
Donepezil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000216	0.00032	CcSEcCtD
Donepezil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000214	0.000317	CcSEcCtD
Donepezil—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000317	CcSEcCtD
Donepezil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000317	CcSEcCtD
Donepezil—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000316	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000316	CcSEcCtD
Donepezil—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000313	CcSEcCtD
Donepezil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.000312	CcSEcCtD
Donepezil—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000312	CcSEcCtD
Donepezil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00031	CcSEcCtD
Donepezil—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00031	CcSEcCtD
Donepezil—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00031	CcSEcCtD
Donepezil—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000309	CcSEcCtD
Donepezil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000208	0.000309	CcSEcCtD
Donepezil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000207	0.000308	CcSEcCtD
Donepezil—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000307	CcSEcCtD
Donepezil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000206	0.000306	CcSEcCtD
Donepezil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000205	0.000305	CcSEcCtD
Donepezil—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000305	CcSEcCtD
Donepezil—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000304	CcSEcCtD
Donepezil—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000303	CcSEcCtD
Donepezil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000204	0.000303	CcSEcCtD
Donepezil—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000302	CcSEcCtD
Donepezil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000203	0.000302	CcSEcCtD
Donepezil—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000302	CcSEcCtD
Donepezil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000203	0.000301	CcSEcCtD
Donepezil—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.0003	CcSEcCtD
Donepezil—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000299	CcSEcCtD
Donepezil—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000299	CcSEcCtD
Donepezil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000201	0.000298	CcSEcCtD
Donepezil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000298	CcSEcCtD
Donepezil—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000201	0.0153	CbGpPWpGaD
Donepezil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.000298	CcSEcCtD
Donepezil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.000296	CcSEcCtD
Donepezil—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000199	0.000295	CcSEcCtD
Donepezil—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000294	CcSEcCtD
Donepezil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000197	0.000293	CcSEcCtD
Donepezil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000293	CcSEcCtD
Donepezil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000197	0.000293	CcSEcCtD
Donepezil—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000291	CcSEcCtD
Donepezil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000196	0.000291	CcSEcCtD
Donepezil—Pain—Etoposide—peripheral nervous system neoplasm	0.000196	0.000291	CcSEcCtD
Donepezil—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00029	CcSEcCtD
Donepezil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00029	CcSEcCtD
Donepezil—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00029	CcSEcCtD
Donepezil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000288	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000194	0.0148	CbGpPWpGaD
Donepezil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000193	0.000287	CcSEcCtD
Donepezil—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000286	CcSEcCtD
Donepezil—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000286	CcSEcCtD
Donepezil—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000285	CcSEcCtD
Donepezil—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000282	CcSEcCtD
Donepezil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000282	CcSEcCtD
Donepezil—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00028	CcSEcCtD
Donepezil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000188	0.00028	CcSEcCtD
Donepezil—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.00028	CcSEcCtD
Donepezil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.000279	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000278	CcSEcCtD
Donepezil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000187	0.000278	CcSEcCtD
Donepezil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000187	0.000277	CcSEcCtD
Donepezil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000277	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000276	CcSEcCtD
Donepezil—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000276	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000186	0.0142	CbGpPWpGaD
Donepezil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.000274	CcSEcCtD
Donepezil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.000274	CcSEcCtD
Donepezil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000184	0.000273	CcSEcCtD
Donepezil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000273	CcSEcCtD
Donepezil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000273	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000272	CcSEcCtD
Donepezil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000182	0.00027	CcSEcCtD
Donepezil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000269	CcSEcCtD
Donepezil—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000268	CcSEcCtD
Donepezil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000268	CcSEcCtD
Donepezil—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000267	CcSEcCtD
Donepezil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00018	0.000267	CcSEcCtD
Donepezil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000266	CcSEcCtD
Donepezil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000266	CcSEcCtD
Donepezil—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000265	CcSEcCtD
Donepezil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000265	CcSEcCtD
Donepezil—Rash—Vincristine—peripheral nervous system neoplasm	0.000178	0.000264	CcSEcCtD
Donepezil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000178	0.000264	CcSEcCtD
Donepezil—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000264	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000263	CcSEcCtD
Donepezil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000263	CcSEcCtD
Donepezil—Headache—Vincristine—peripheral nervous system neoplasm	0.000177	0.000263	CcSEcCtD
Donepezil—ACHE—Peptide hormone metabolism—BCHE—peripheral nervous system neoplasm	0.000177	0.0135	CbGpPWpGaD
Donepezil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000261	CcSEcCtD
Donepezil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.000259	CcSEcCtD
Donepezil—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000258	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000173	0.0132	CbGpPWpGaD
Donepezil—ACHE—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	0.000172	0.0131	CbGpPWpGaD
Donepezil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000254	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000252	CcSEcCtD
Donepezil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000169	0.00025	CcSEcCtD
Donepezil—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00025	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000249	CcSEcCtD
Donepezil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000168	0.000249	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000249	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000248	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000248	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000247	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000246	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000245	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000244	CcSEcCtD
Donepezil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000164	0.000244	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000243	CcSEcCtD
Donepezil—Chills—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000241	CcSEcCtD
Donepezil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000162	0.00024	CcSEcCtD
Donepezil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000239	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000239	CcSEcCtD
Donepezil—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000237	CcSEcCtD
Donepezil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000236	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000235	CcSEcCtD
Donepezil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000234	CcSEcCtD
Donepezil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000234	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000233	CcSEcCtD
Donepezil—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000233	CcSEcCtD
Donepezil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000156	0.000232	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000231	CcSEcCtD
Donepezil—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00023	CcSEcCtD
Donepezil—Tension—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000229	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000229	CcSEcCtD
Donepezil—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000227	CcSEcCtD
Donepezil—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000226	CcSEcCtD
Donepezil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000151	0.000225	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000224	CcSEcCtD
Donepezil—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000223	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000222	CcSEcCtD
Donepezil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000148	0.00022	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00022	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000219	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000217	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000217	CcSEcCtD
Donepezil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000145	0.000216	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000216	CcSEcCtD
Donepezil—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000216	CcSEcCtD
Donepezil—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000216	CcSEcCtD
Donepezil—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000214	CcSEcCtD
Donepezil—Rash—Etoposide—peripheral nervous system neoplasm	0.000144	0.000214	CcSEcCtD
Donepezil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000144	0.000214	CcSEcCtD
Donepezil—HRH3—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000144	0.011	CbGpPWpGaD
Donepezil—Headache—Etoposide—peripheral nervous system neoplasm	0.000143	0.000213	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000213	CcSEcCtD
Donepezil—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000212	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000211	CcSEcCtD
Donepezil—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00021	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00021	CcSEcCtD
Donepezil—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00021	CcSEcCtD
Donepezil—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000209	CcSEcCtD
Donepezil—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000209	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000208	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000205	CcSEcCtD
Donepezil—Cough—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000204	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000203	CcSEcCtD
Donepezil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000202	CcSEcCtD
Donepezil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000136	0.000202	CcSEcCtD
Donepezil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000201	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.0002	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.0002	CcSEcCtD
Donepezil—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000199	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000199	CcSEcCtD
Donepezil—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000199	CcSEcCtD
Donepezil—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000198	CcSEcCtD
Donepezil—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000198	CcSEcCtD
Donepezil—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000196	CcSEcCtD
Donepezil—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000195	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000194	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000194	CcSEcCtD
Donepezil—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000194	CcSEcCtD
Donepezil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000129	0.00987	CbGpPWpGaD
Donepezil—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000192	CcSEcCtD
Donepezil—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00019	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00019	CcSEcCtD
Donepezil—Infection—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000189	CcSEcCtD
Donepezil—HTR2A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000127	0.00969	CbGpPWpGaD
Donepezil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000188	CcSEcCtD
Donepezil—Shock—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000187	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000187	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000187	CcSEcCtD
Donepezil—HRH3—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000126	0.00958	CbGpPWpGaD
Donepezil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000186	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000186	CcSEcCtD
Donepezil—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—NRAS—peripheral nervous system neoplasm	0.000125	0.00952	CbGpPWpGaD
Donepezil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000184	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000184	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000184	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000184	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000183	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000182	CcSEcCtD
Donepezil—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000182	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00018	CcSEcCtD
Donepezil—ACHE—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	0.00012	0.00915	CbGpPWpGaD
Donepezil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000178	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000178	CcSEcCtD
Donepezil—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000176	CcSEcCtD
Donepezil—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000118	0.00902	CbGpPWpGaD
Donepezil—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000175	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000174	CcSEcCtD
Donepezil—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000173	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000173	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000173	CcSEcCtD
Donepezil—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000172	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000171	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00017	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00017	CcSEcCtD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000114	0.00871	CbGpPWpGaD
Donepezil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000169	CcSEcCtD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000114	0.00867	CbGpPWpGaD
Donepezil—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000168	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000168	CcSEcCtD
Donepezil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000113	0.00859	CbGpPWpGaD
Donepezil—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000166	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000165	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000164	CcSEcCtD
Donepezil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000164	CcSEcCtD
Donepezil—Pain—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000163	CcSEcCtD
Donepezil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000163	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000109	0.00835	CbGpPWpGaD
Donepezil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000161	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000159	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000158	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000157	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000157	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000157	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000156	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000155	CcSEcCtD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000104	0.00796	CbGpPWpGaD
Donepezil—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000153	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000152	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000152	CcSEcCtD
Donepezil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000151	CcSEcCtD
Donepezil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000151	CcSEcCtD
Donepezil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000151	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000151	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000151	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	9.93e-05	0.00758	CbGpPWpGaD
Donepezil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000145	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000144	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.52e-05	0.00727	CbGpPWpGaD
Donepezil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.00014	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.00014	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000139	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000139	CcSEcCtD
Donepezil—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000137	CcSEcCtD
Donepezil—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—peripheral nervous system neoplasm	9.13e-05	0.00696	CbGpPWpGaD
Donepezil—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.07e-05	0.000135	CcSEcCtD
Donepezil—ACHE—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	8.91e-05	0.0068	CbGpPWpGaD
Donepezil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.77e-05	0.00013	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.00013	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.7e-05	0.00664	CbGpPWpGaD
Donepezil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000126	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	8.48e-05	0.00647	CbGpPWpGaD
Donepezil—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.48e-05	0.000126	CcSEcCtD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	8.42e-05	0.00642	CbGpPWpGaD
Donepezil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.000125	CcSEcCtD
Donepezil—HRH3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.29e-05	0.00633	CbGpPWpGaD
Donepezil—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.15e-05	0.000121	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000121	CcSEcCtD
Donepezil—Rash—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.00012	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.00012	CcSEcCtD
Donepezil—Headache—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000119	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000117	CcSEcCtD
Donepezil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	7.8e-05	0.00595	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	7.73e-05	0.0059	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	7.72e-05	0.00589	CbGpPWpGaD
Donepezil—Nausea—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000113	CcSEcCtD
Donepezil—HRH3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.61e-05	0.0058	CbGpPWpGaD
Donepezil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.000112	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.53e-05	0.00574	CbGpPWpGaD
Donepezil—Rash—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.000111	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000111	CcSEcCtD
Donepezil—Headache—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.00011	CcSEcCtD
Donepezil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.43e-05	0.00567	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	7.08e-05	0.0054	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	7.07e-05	0.00539	CbGpPWpGaD
Donepezil—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000105	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	6.96e-05	0.00531	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	6.95e-05	0.0053	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.88e-05	0.00525	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—BCHE—peripheral nervous system neoplasm	6.83e-05	0.00521	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	6.41e-05	0.00489	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	6.14e-05	0.00469	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.87e-05	0.00448	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	5.76e-05	0.00439	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	5.71e-05	0.00436	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.63e-05	0.00429	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	5.11e-05	0.0039	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.92e-05	0.00375	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.65e-05	0.00354	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.46e-05	0.00341	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.45e-05	0.00339	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.3e-05	0.00328	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.24e-05	0.00324	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.1e-05	0.00313	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.9e-05	0.00298	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.9e-05	0.00297	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.86e-05	0.00294	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.78e-05	0.00288	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.62e-05	0.00276	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.54e-05	0.0027	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GNS—peripheral nervous system neoplasm	3.36e-05	0.00256	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3.34e-05	0.00254	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.29e-05	0.00251	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NME1—peripheral nervous system neoplasm	3.22e-05	0.00246	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.15e-05	0.00241	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	3.1e-05	0.00237	CbGpPWpGaD
Donepezil—ACHE—Metabolism—COX2—peripheral nervous system neoplasm	3.1e-05	0.00236	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.08e-05	0.00235	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.88e-05	0.0022	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.88e-05	0.0022	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.82e-05	0.00215	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.8e-05	0.00213	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.76e-05	0.00211	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.74e-05	0.00209	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.71e-05	0.00207	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.64e-05	0.00201	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.52e-05	0.00192	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.51e-05	0.00192	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.49e-05	0.0019	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.31e-05	0.00176	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.3e-05	0.00175	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.27e-05	0.00173	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.09e-05	0.00159	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ENO2—peripheral nervous system neoplasm	2.03e-05	0.00155	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.94e-05	0.00148	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.92e-05	0.00146	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.91e-05	0.00145	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.89e-05	0.00144	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.87e-05	0.00142	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.86e-05	0.00142	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.84e-05	0.00141	CbGpPWpGaD
Donepezil—ACHE—Metabolism—BCHE—peripheral nervous system neoplasm	1.72e-05	0.00131	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.64e-05	0.00125	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.63e-05	0.00124	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.63e-05	0.00124	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TH—peripheral nervous system neoplasm	1.62e-05	0.00123	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.6e-05	0.00122	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—HRAS—peripheral nervous system neoplasm	1.6e-05	0.00122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.57e-05	0.0012	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.48e-05	0.00113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.47e-05	0.00112	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.42e-05	0.00109	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.38e-05	0.00105	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.37e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.37e-05	0.00104	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.36e-05	0.00104	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.32e-05	0.00101	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GNAS—peripheral nervous system neoplasm	1.32e-05	0.00101	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.31e-05	0.000999	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCB1—peripheral nervous system neoplasm	1.29e-05	0.000988	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.29e-05	0.000986	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.27e-05	0.00097	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.27e-05	0.000966	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.26e-05	0.000961	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.25e-05	0.00095	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.19e-05	0.00091	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000885	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.15e-05	0.000877	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.05e-05	0.000804	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.02e-05	0.000779	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.64e-06	0.000735	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	9.01e-06	0.000687	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.98e-06	0.000685	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.98e-06	0.000685	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.73e-06	0.000666	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.63e-06	0.000659	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	8.35e-06	0.000637	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.32e-06	0.000635	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.31e-06	0.000634	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	8.27e-06	0.000631	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.63e-06	0.000582	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.37e-06	0.000562	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	7.05e-06	0.000538	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.05e-06	0.000538	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.99e-06	0.000533	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.73e-06	0.000513	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.67e-06	0.000509	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	6.63e-06	0.000506	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.57e-06	0.000501	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.22e-06	0.000475	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.46e-06	0.000416	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	5.41e-06	0.000413	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.4e-06	0.000412	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.37e-06	0.000409	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.31e-06	0.000405	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.31e-06	0.000405	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.27e-06	0.000402	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.61e-06	0.000352	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.4e-06	0.000336	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.33e-06	0.000331	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.19e-06	0.00032	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.95e-06	0.000301	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.84e-06	0.000293	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.81e-06	0.00029	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—peripheral nervous system neoplasm	3.56e-06	0.000272	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.54e-06	0.00027	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.49e-06	0.000266	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.47e-06	0.000265	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.19e-06	0.000243	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.97e-06	0.000227	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.44e-06	0.000186	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.33e-06	0.000178	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.06e-06	0.000157	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.46e-06	0.000111	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.45e-06	0.00011	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.55e-07	7.29e-05	CbGpPWpGaD
